Compared with the normal control group, at least two of the three gastrointestinal cancers including gastric cancer group, the esophageal cancer group, and the colorectal cancer group, were significantly elevated in terms of the levels of anti‐PAIP1 and anti‐SARS in sera. This evidence concerns the gene PAIP1 and gastric cancer.